Review: taking Doxycycline hyclate and Macrobid together


Summary

Drug interactions are reported among people who take Doxycycline hyclate and Macrobid together. This review analyzes the effectiveness and drug interactions between Doxycycline hyclate and Macrobid. It is created by eHealthMe based on reports of 118 people who take the same drugs from FDA and social media, and is updated regularly.

You are not alone

Join a support group for people who take Doxycycline hyclate and Macrobid >>>

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>


Doxycycline Hyclate

Doxycycline hyclate has active ingredients of doxycycline hyclate. It is often used in acne. (latest outcomes from Doxycycline hyclate 2,354 users)

Macrobid

Macrobid has active ingredients of nitrofurantoin; nitrofurantoin, macrocrystalline. It is often used in urinary tract infection. (latest outcomes from Macrobid 3,402 users)

On Jul, 20, 2016

118 people who take Doxycycline Hyclate, Macrobid are studied.


Number of reports submitted per year:

Doxycycline hyclate and Macrobid drug interactions.

Drug effectiveness over time:

Doxycycline Hyclate:
  • < 1 month: 0.0% - (0 of 0 people)
  • 1 - 6 months: 0.0% - (0 of 0 people)
  • 6 - 12 months: 0.0% - (0 of 0 people)
  • 1 - 2 years: 100.0% - (1 of 1 people)
  • 2 - 5 years: 0.0% - (0 of 0 people)
  • 5 - 10 years: 0.0% - (0 of 0 people)
  • 10+ years: 0.0% - (0 of 0 people)
  • not specified: 0.0% - (0 of 0 people)
Macrobid:
  • < 1 month: 100.0% - (1 of 1 people)
  • 1 - 6 months: 0.0% - (0 of 0 people)
  • 6 - 12 months: 0.0% - (0 of 0 people)
  • 1 - 2 years: 0.0% - (0 of 0 people)
  • 2 - 5 years: 0.0% - (0 of 0 people)
  • 5 - 10 years: 0.0% - (0 of 0 people)
  • 10+ years: 0.0% - (0 of 0 people)
  • not specified: 0.0% - (0 of 0 people)

Drug effectiveness by gender:

Doxycycline Hyclate:
  • female: 0.0% - (0 of 0 people)
  • male: 100.0% - (1 of 1 people)
Macrobid:
  • female: 0.0% - (0 of 0 people)
  • male: 100.0% - (1 of 1 people)

Drug effectiveness by age:

Doxycycline Hyclate:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 0 people)
  • 30-39: 100.0% - (1 of 1 people)
  • 40-49: 0.0% - (0 of 0 people)
  • 50-59: 0.0% - (0 of 0 people)
  • 60+: 0.0% - (0 of 0 people)
Macrobid:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 0 people)
  • 30-39: 100.0% - (1 of 1 people)
  • 40-49: 0.0% - (0 of 0 people)
  • 50-59: 0.0% - (0 of 0 people)
  • 60+: 0.0% - (0 of 0 people)

Most common drug interactions over time *:

< 1 month:
  • deafness
  • abdominal distension
  • acute myocardial infarction
  • blood cholesterol abnormal
  • cardiac disorder
  • cholecystitis chronic
  • constipation
  • convulsion
  • depression
  • anxiety
2 - 5 years:
  • pulmonary fibrosis
5 - 10 years:
  • anxiety
  • convulsion
  • discomfort
  • fractured coccyx
  • fractured sacrum
  • loss of consciousness
  • lumbar vertebral fracture
  • muscle spasms
not specified:
  • urinary tract infection
  • pain
  • dyspnoea
  • fall
  • nausea
  • oedema peripheral
  • anaemia
  • anxiety
  • asthenia
  • chronic obstructive pulmonary disease

Most common drug interactions by gender *:

female:
  • urinary tract infection
  • pain
  • anxiety
  • dyspnoea
  • fall
  • oedema peripheral
  • nausea
  • anaemia
  • asthenia
  • chronic obstructive pulmonary disease
male:
  • pyrexia
  • deafness
  • dysuria
  • presyncope
  • tricuspid valve incompetence
  • abdominal pain
  • angina pectoris
  • atrial fibrillation
  • back pain
  • benign prostatic hyperplasia

Most common drug interactions by age *:

10-19:
  • abdominal pain
  • abdominal pain lower
  • abdominal pain upper
  • bile duct stone
  • cholelithiasis
  • decreased appetite
  • enuresis
  • gallbladder disorder
  • jaundice
  • nausea
20-29:
  • pain
  • actinomyces test positive
  • acute psychosis
  • amnesia
  • asthenia
  • bone disorder
  • breath odour
  • bronchitis
  • candidiasis
  • cellulitis
30-39:
  • nausea
  • abdominal pain
  • cholelithiasis
  • vomiting
  • gallbladder disorder
  • pulmonary embolism
  • anxiety
  • cholesterosis
  • deep vein thrombosis
  • depression
40-49:
  • chronic obstructive pulmonary disease
  • pneumonia
  • fatigue
  • abdominal distension
  • drug ineffective
  • fall
  • weight increased
  • acute myocardial infarction
  • amnesia
  • anxiety
50-59:
  • anxiety
  • urinary tract infection
  • asthenia
  • dyspnoea
  • injury
  • pain
  • atrial fibrillation
  • dyspnoea exertional
  • gastrooesophageal reflux disease
  • hypoaesthesia
60+:
  • presyncope
  • nausea
  • dyspnoea
  • hypertension
  • injury
  • anxiety
  • arthralgia
  • cardiac failure congestive
  • cough
  • chronic obstructive pulmonary disease

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you take Doxycycline hyclate and Macrobid?

Can you answer these questions?

More questions for: Doxycycline hyclate, Macrobid

You may be interested in these reviews

More reviews for: Doxycycline hyclate, Macrobid

On eHealthMe, Doxycycline hyclate (doxycycline hyclate) is often used to treat acne. Macrobid (nitrofurantoin; nitrofurantoin, macrocrystalline) is often used to treat urinary tract infection. Find out below the conditions the drugs are used for and how effective they are.

What is the drug used for and how effecitve is it:


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.